DalsnaFinance › IPOs › Acurx Pharmaceuticals › IPO
Acurx Pharmaceuticals, Inc. completed its initial public offering on NASDAQ on June 25, 2021, pricing at $6.00 a share.
| Ticker | ACXP |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | June 25, 2021 |
| Offering price | $6.00 |
| Shares offered | 2,500,000 |
| Total raised | $15M |
Acurx Pharmaceuticals, Inc. sold 2,500,000 shares at $6.00 each on NASDAQ. Multiplied out, that is $15 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $15 million total recorded for the deal.
Acurx Pharmaceuticals, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Acurx Pharmaceuticals, Inc.. This page is general information, not investment advice.